DNMT3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.336300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.641300E-03
Normal-vs-Stage2
4.186200E-02
Normal-vs-Stage3
1.796170E-02
Normal-vs-Stage4
4.334200E-01
Stage1-vs-Stage2
8.712400E-01
Stage1-vs-Stage3
1.345810E-01
Stage1-vs-Stage4
5.076200E-01
Stage2-vs-Stage3
1.403420E-01
Stage2-vs-Stage4
3.593400E-01
Stage3-vs-Stage4
1.894390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.912100E-02
Normal-vs-AfricanAmerican
2.072200E-02
Normal-vs-Asian
4.972000E-02
Caucasian-vs-AfricanAmerican
8.048800E-01
Caucasian-vs-Asian
7.111600E-01
AfricanAmerican-vs-Asian
9.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.650400E-02
Normal-vs-Female
2.472100E-02
Male-vs-Female
8.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.437600E-01
Normal-vs-Age(41-60Yrs)
4.679900E-02
Normal-vs-Age(61-80Yrs)
2.655500E-02
Normal-vs-Age(81-100Yrs)
2.588200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.131200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.603420E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.144200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.761800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.769200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.617800E-02
Normal-vs-Daily Drinker
1.152310E-02
Normal-vs-Weekly Drinker
5.148300E-02
Normal-vs-Occasional Drinker
2.352000E-02
Normal-vs-Social Drinker
6.921500E-02
Non Drinker-vs-Daily Drinker
3.788800E-01
Non Drinker-vs-Weekly Drinker
9.986800E-01
Non Drinker-vs-Occasional Drinker
7.142800E-01
Non Drinker-vs-Social Drinker
4.668000E-01
Daily Drinker-vs-Weekly Drinker
3.952400E-01
Daily Drinker-vs-Occasional Drinker
1.671560E-01
Daily Drinker-vs-Social Drinker
8.100300E-02
Weekly Drinker-vs-Occasional Drinker
7.316200E-01
Weekly Drinker-vs-Social Drinker
4.482800E-01
Occasional Drinker-vs-Social Drinker
5.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.666100E-02
Normal-vs-Grade 2
1.250130E-02
Normal-vs-Grade 3
8.421300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.798600E-01
Grade 1-vs-Grade 3
1.343800E-02
Grade 1-vs-Grade 4
9.666100E-02
Grade 2-vs-Grade 3
1.568190E-02
Grade 2-vs-Grade 4
1.250130E-02
Grade 3-vs-Grade 4
8.421300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.853700E-02
Normal-vs-NonDiabetic
3.259600E-02
Diabetic-vs-NonDiabetic
6.036200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.340100E-02
Normal-vs-NoPancreatitis
2.944200E-02
Pancreatitis-vs-NoPancreatitis
1.910790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.185900E-02
Normal-vs-N1
4.819700E-02
N0-vs-N1
4.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.102000E-02
Normal-vs-TP53-NonMutant
3.258400E-02
TP53-Mutant-vs-TP53-NonMutant
1.045360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
